| Molecular subtypes of pulmonary large-cell neuroendocrine carcinoma predict chemotherapy treatment outcome JL Derks, N Leblay, E Thunnissen, RJ Van Suylen, M den Bakker, ... Clinical Cancer Research 24 (1), 33-42, 2018 | 194 | 2018 |
| Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids N Alcala, N Leblay, AAG Gabriel, L Mangiante, D Hervás, T Giffon, ... Nature communications 10 (1), 3407, 2019 | 171 | 2019 |
| New insights into the molecular characteristics of pulmonary carcinoids and large cell neuroendocrine carcinomas, and the impact on their clinical management JL Derks, N Leblay, S Lantuejoul, AMC Dingemans, EJM Speel, ... Journal of Thoracic Oncology 13 (6), 752-766, 2018 | 132 | 2018 |
| Clinical features of large cell neuroendocrine carcinoma: a population-based overview JL Derks, LE Hendriks, WA Buikhuisen, HJM Groen, E Thunnissen, ... European Respiratory Journal 47 (2), 615-624, 2016 | 127 | 2016 |
| Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter? JL Derks, RJ Van Suylen, E Thunnissen, MA Den Bakker, HJ Groen, ... European Respiratory Journal 49 (6), 2017 | 111 | 2017 |
| Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: results from a population-based study LE Hendriks, JL Derks, PE Postmus, RA Damhuis, RMA Houben, ... European journal of cancer 51 (17), 2534-2544, 2015 | 63 | 2015 |
| Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer C Kuijpers, LEL Hendriks, JL Derks, AMC Dingemans, ASR Van Lindert, ... Lung Cancer 121, 76-81, 2018 | 62 | 2018 |
| DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile BCM Hermans, JL Derks, E Thunnissen, RJ van Suylen, MA den Bakker, ... Lung Cancer 138, 102-108, 2019 | 54 | 2019 |
| KRAS mutations in advanced nonsquamous non–small-cell lung cancer patients treated with first-line platinum-based chemotherapy have no predictive value WW Mellema, AMC Dingemans, E Thunnissen, PJF Snijders, J Derks, ... Journal of thoracic oncology 8 (9), 1190-1195, 2013 | 53 | 2013 |
| Clinical-pathologic challenges in the classification of pulmonary neuroendocrine neoplasms and targets on the horizon for future clinical practice JL Derks, N Rijnsburger, BCM Hermans, L Moonen, LM Hillen, ... Journal of Thoracic Oncology 16 (10), 1632-1646, 2021 | 42 | 2021 |
| Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens? JL Derks, AMC Dingemans, RJ van Suylen, MA den Bakker, ... Histopathology 74 (4), 555-566, 2019 | 39 | 2019 |
| Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC) BCM Hermans, JL Derks, E Thunnissen, RJ Van Suylen, MA Den Bakker, ... Lung Cancer 130, 179-186, 2019 | 37 | 2019 |
| Orthopedia homeobox (OTP) in pulmonary neuroendocrine tumors: the diagnostic value and possible molecular interactions L Moonen, J Derks, AM Dingemans, EJ Speel Cancers 11 (10), 1508, 2019 | 28 | 2019 |
| Pulmonary neuroendocrine neoplasms with well differentiated morphology and high proliferative activity: illustrated by a case series and review of the literature BCM Hermans, JL Derks, L Moonen, CHJ Habraken, J von der Thüsen, ... Lung Cancer 150, 152-158, 2020 | 25 | 2020 |
| Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites TL Dayton, N Alcala, L Moonen, L den Hartigh, V Geurts, L Mangiante, ... Cancer Cell 41 (12), 2083-2099. e9, 2023 | 23 | 2023 |
| Preoperative biopsy diagnosis in pulmonary carcinoids, a shot in the dark L Moonen, JL Derks, BCM Hermans, IM Bunnik, LM Hillen, RJ van Suylen, ... Journal of Thoracic Oncology 16 (4), 610-618, 2021 | 19 | 2021 |
| Unique metastatic patterns in neuroendocrine neoplasms of different primary origin BCM Hermans, J de Vos-Geelen, JL Derks, L Latten, IH Liem, ... Neuroendocrinology 111 (11), 1111-1120, 2021 | 18 | 2021 |
| A population-based analysis of application of WHO nomenclature in pathology reports of pulmonary neuroendocrine tumors JL Derks, RJ van Suylen, E Thunnissen, MA den Bakker, EF Smit, ... Journal of Thoracic Oncology 11 (4), 593-602, 2016 | 18 | 2016 |
| Neuroendocrine cancer of the lung: a diagnostic puzzle JL Derks, EJM Speel, E Thunnissen, RJ van Suylen, WA Buikhuisen, ... Journal of thoracic oncology 11 (3), e35-e38, 2016 | 14 | 2016 |
| Genetic subtypes of large cell neuroendocrine carcinoma (LCNEC) to predict response to chemotherapy. J Derks, N Leblay, RJ van Suylen, E Thunnissen, M den Bakker, ... Journal of Clinical Oncology 35 (15_suppl), 9061-9061, 2017 | 8 | 2017 |
